Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus
Spanish Journal of Psychiatry and Mental Health · 2023
DOI: 10.1016/j.rpsm.2020.04.013 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Spanish Journal of Psychiatry and Mental Health, 2023. Verfasst von Raul Felipe Palma-Álvarez und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, Universitat Autònoma…. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Substance-Related Disorders. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swiss Foundation for Alcohol Research, Sykehuset Østfold, Ministerio de Sanidad, Política Social e Igualdad.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
OBJECTIVE: This study aims to assess the validity of the ADHD module of the Mini-International Neuropsychiatric Interview (MINI-Plus) in patients with substance use disorders (SUD), using the Conners' Adult ADHD Diagnostic Interview for DSM-IV (CAADID) as the external criterion. METHOD: A cross sectional international multi-center study in 10 countries was conducted in treatment seeking SUD patients. A sample of 1263 patients with both MINI-Plus and CAADID was analyzed to determine the psychometric properties of the MINI-Plus. RESULTS: According to the CAADID, 179 patients (14.2%) met criteria for adult ADHD, whereas according to the MINI-Plus 227 patients (18.0%) were identified as having adult ADHD. Sensitivity of the MINI-Plus ADHD module was 74%, specificity was 91%, positive predictive value was 60% and negative predictive value was 96%. Kappa was 0.60. CONCLUSION: The MINI-Plus has acceptable criterion validity for the screening of adult ADHD in treatment seeking SUD patients. SCIENTIFIC SIGNIFICANCE: On the basis of the results, The MINI-Plus may be used for the screening of ADHD in SUD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
- Institute of Medical Chemistry, Molecular Biology, Pathobiochemistry, Semmelweis University, Budapest, Hungary.
- Reinier van Arkel mental health institute, 's-Hertogenbosch, The Netherlands.
- National Drug Research Institute, Curtin University, Perth, Australia.
- Department of Psychiatry, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium; Toxicological Center, Antwerp University, Antwerp, Belgium.
- Institute of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary.
Förderung
- Swiss Foundation for Alcohol Research
- Sykehuset Østfold
- Ministerio de Sanidad, Política Social e Igualdad
- Generalitat de Catalunya
- European Commission
- European Social Fund Plus
- Agència de Salut Pública de Barcelona
- Regionalt Kompetansesenter for Rusmiddelforskning i Helse Vest
Zitieren
APA
Palma-Álvarez, R. F., Barta, C., Carpentier, P. J., Carruthers, S., Crunelle, C. L., Demetrovics, Z., Dom, G., Faraone, S. V., Franck, J., Johnson, B., Kapitány-Fövény, M., Kaye, S., Konstenius, M., Matthys, F., Moggi, F., Møller, M., Schellekens, A., Skutle, A., van de Glind, G., …, & IASP Research Group (2023). Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus. Spanish Journal of Psychiatry and Mental Health. https://doi.org/10.1016/j.rpsm.2020.04.013
Vancouver
Palma-Álvarez RF, Barta C, Carpentier PJ, Carruthers S, Crunelle CL, Demetrovics Z, et al. Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus. Spanish Journal of Psychiatry and Mental Health. 2023. doi:10.1016/j.rpsm.2020.04.013
BibTeX
@article{Palmalvarez2023,
author = {Palma-Álvarez, Raul Felipe and Barta, Csaba and Carpentier, Pieter Jan and Carruthers, Susan and Crunelle, Cleo L and Demetrovics, Zsolt and Dom, Geert and Faraone, Stephen V and Franck, Johan and Johnson, Brian and Kapitány-Fövény, Máté and Kaye, Sharlene and Konstenius, Maija and Matthys, Frieda and Moggi, Franz and Møller, Merete and Schellekens, Arnt and Skutle, Arvid and van de Glind, Geurt and van Emmerik-van Oortmerssen, Katelijne and Verspreet, Sofie and Schoevers, Robert A and Wallhed, Sara and Levin, Frances R and Grau-López, Lara and Casas, Miguel and van den Brink, Wim and Ramos-Quiroga, Josep Antoni and IASP Research Group, IASP Research Group},
title = {Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus},
journal = {Spanish Journal of Psychiatry and Mental Health},
year = {2023},
doi = {10.1016/j.rpsm.2020.04.013}
}
EUVIMED